Robots and software aren’t just changing manual labor in warehouses or kitchens. They’re also transforming medical research.
A San Francisco startup called 3Scan Inc. raised $14 million in venture funding to automate tissue analysis for scientists involved in drug discovery with its proprietary robotic microscope and computer vision systems.
Today, if researchers need to examine diseased tissue, they typically attain a 1 cm block of it, embed it in something like paraffin then slice it into sections that are stained, floated in a water bath and examined under different kinds of microscopes.
3Scan’s machine is so efficient that it can do a year’s worth of tissue sample analysis in one day that it would take a pathologist to do in one year using traditional methods, Klimen said.